Cumberland Accounts Payable vs Total Liab Analysis
CPIX Stock | USD 1.48 0.03 2.07% |
Cumberland Pharmaceuticals financial indicator trend analysis is way more than just evaluating Cumberland Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cumberland Pharmaceuticals is a good investment. Please check the relationship between Cumberland Pharmaceuticals Accounts Payable and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cumberland Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.
Accounts Payable vs Total Liab
Accounts Payable vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cumberland Pharmaceuticals Accounts Payable account and Total Liab. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Cumberland Pharmaceuticals' Accounts Payable and Total Liab is 0.84. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Liab in the same time period over historical financial statements of Cumberland Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Cumberland Pharmaceuticals' Accounts Payable and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Cumberland Pharmaceuticals are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Accounts Payable i.e., Cumberland Pharmaceuticals' Accounts Payable and Total Liab go up and down completely randomly.
Correlation Coefficient | 0.84 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Accounts Payable
An accounting item on the balance sheet that represents Cumberland Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Cumberland Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most indicators from Cumberland Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cumberland Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cumberland Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.Discontinued Operations is likely to rise to about 2.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 8.9 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 98.0K | 586.0K | 667.9K | 701.3K | Depreciation And Amortization | 6.8M | 5.4M | 5.8M | 6.1M |
Cumberland Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Cumberland Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cumberland Pharmaceuticals fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 104.5M | 96.5M | 84.5M | 92.9M | 81.8M | 88.1M | |
Short Long Term Debt Total | 21.5M | 17.1M | 16.1M | 21.0M | 18.4M | 11.9M | |
Other Current Liab | 7.7M | 11.3M | 8.7M | 17.6M | 13.6M | 7.8M | |
Total Current Liabilities | 24.2M | 25.7M | 19.3M | 28.6M | 28.0M | 16.8M | |
Total Stockholder Equity | 51.1M | 47.0M | 42.8M | 36.3M | 29.6M | 58.3M | |
Property Plant And Equipment Net | 3.7M | 2.6M | 1.5M | 5.5M | 7.0M | 7.4M | |
Net Debt | (6.7M) | (7.7M) | (11.0M) | 1.2M | 106.9K | 112.2K | |
Retained Earnings | 1.2M | (2.1M) | (5.6M) | (11.2M) | (17.5M) | (16.6M) | |
Accounts Payable | 10.0M | 13.4M | 9.6M | 10.8M | 14.0M | 14.7M | |
Cash | 28.2M | 24.8M | 27.0M | 19.8M | 18.3M | 27.3M | |
Non Current Assets Total | 54.4M | 46.5M | 38.8M | 47.1M | 46.1M | 27.5M | |
Cash And Short Term Investments | 28.2M | 24.8M | 27.0M | 19.8M | 18.3M | 31.1M | |
Net Receivables | 7.9M | 12.4M | 6.9M | 13.2M | 9.8M | 7.4M | |
Common Stock Shares Outstanding | 15.4M | 15.2M | 14.9M | 14.6M | 14.3M | 13.5M | |
Liabilities And Stockholders Equity | 104.5M | 96.5M | 84.5M | 92.9M | 81.8M | 88.1M | |
Non Current Liabilities Total | 29.3M | 23.9M | 22.6M | 28.4M | 24.5M | 13.1M | |
Inventory | 8.9M | 10.6M | 8.4M | 9.4M | 4.6M | 7.3M | |
Other Current Assets | 2.8M | 2.2M | 3.3M | 3.5M | 3.0M | 2.3M | |
Other Stockholder Equity | 2.9M | 3.1M | 3.4M | (212.3K) | (244.2K) | (256.4K) | |
Total Liab | 53.5M | 49.6M | 41.9M | 57.0M | 52.5M | 29.9M | |
Property Plant And Equipment Gross | 3.7M | 2.6M | 1.5M | 5.5M | 9.3M | 9.7M | |
Total Current Assets | 50.2M | 50.0M | 45.7M | 45.9M | 35.7M | 60.5M | |
Intangible Assets | 30.9M | 28.1M | 24.0M | 30.6M | 22.6M | 19.2M | |
Non Currrent Assets Other | 18.9M | 14.9M | 12.5M | 10.0M | 15.5M | 16.3M | |
Other Liab | 8.7M | 7.9M | 7.5M | 7.6M | 8.7M | 9.2M | |
Other Assets | 18.9M | 17.8M | 12.5M | 10.0M | 11.6M | 7.4M | |
Long Term Debt | 20M | 18.5M | 15M | 16.2M | 12.8M | 9.3M | |
Common Stock | 49.9M | 49.1M | 48.5M | 47.5M | 47.1M | 44.7M | |
Property Plant Equipment | 16.3M | 12.2M | 1.5M | 5.5M | 6.3M | 6.6M | |
Net Tangible Assets | 19.3M | 18.0M | 18.0M | 4.8M | 4.3M | 4.1M | |
Noncontrolling Interest In Consolidated Entity | (198.6K) | (274.3K) | (37.6K) | (117.1K) | (105.4K) | (110.7K) | |
Common Stock Total Equity | 52.4M | 51.1M | 49.9M | 49.1M | 44.2M | 46.2M | |
Retained Earnings Total Equity | 11.7M | 4.7M | 1.2M | (2.1M) | (1.9M) | (1.8M) | |
Long Term Debt Total | 9.8M | 20M | 18.5M | 15M | 17.3M | 10.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cumberland Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cumberland Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cumberland Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cumberland Pharmaceuticals Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cumberland Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Cumberland Stock analysis
When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Global Correlations Find global opportunities by holding instruments from different markets |
Is Cumberland Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cumberland Pharmaceuticals. If investors know Cumberland will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cumberland Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Revenue Per Share 2.728 | Quarterly Revenue Growth (0.08) | Return On Assets (0.05) | Return On Equity (0.27) |
The market value of Cumberland Pharmaceuticals is measured differently than its book value, which is the value of Cumberland that is recorded on the company's balance sheet. Investors also form their own opinion of Cumberland Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cumberland Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cumberland Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cumberland Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cumberland Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cumberland Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cumberland Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.